David Shaw’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

David Shaw’s Portfolio SZYM Stock Details SZYM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-205,535	Closed	-$417K	–	3699
2016 Q1	$417K	Buy	205,535 +35,814	+21%	+$63.9K	﹤0.01%	2872
2015 Q4	$421K	Buy	169,721 +82,868	+95%	+$246K	﹤0.01%	3181
2015 Q3	$226K	Sell	86,853 -12,200	-12%	-$31.8K	﹤0.01%	3458
2015 Q2	$311K	Sell	99,053 -129,896	-57%	-$445K	﹤0.01%	3397
2015 Q1	$655K	Buy	228,949 +98,617	+76%	+$252K	﹤0.01%	2890
2014 Q4	$336K	Buy	+130,332	New	+$570K	﹤0.01%	3588
2014 Q2	–	Sell	-17,194	Closed	-$200K	–	4803
2014 Q1	$200K	Buy	+17,194	New	+$202K	﹤0.01%	4085

David Shaw's SZYM Position: Q2 2016 in Review

David Shaw sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 205,535 shares — an estimated $417K sold.

David Shaw first reported a position in SZYM in Q1 2014 and held it in 7 quarters. The position peaked at $655K in Q1 2015. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

David Shaw reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
David Shaw sold 205,535 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $417K.
David Shaw first reported a position in SOLAZYME INC COM STK (DE) in Q1 2014 and held it in 7 quarters.
David Shaw's SOLAZYME INC COM STK (DE) position peaked at $655K in Q1 2015.
0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on D.E. Shaw & Co's 13F filing for Q2 2016, filed 15 Aug 2016.